Applied Therapeutics, Inc. Operating Lease, Liability, Noncurrent
Applied Therapeutics, Inc. had Operating Lease, Liability, Noncurrent of $2.03 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2025-11-13
- 2025-09-30: Operating Lease, Liability, Noncurrent $2.03M.
- 2025-06-30: Operating Lease, Liability, Noncurrent $2.15M.
- 2025-03-31: Operating Lease, Liability, Noncurrent $2.27M.
- 2024-12-31: Operating Lease, Liability, Noncurrent $2.39M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2025-09-30 | $2.03M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.15M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.27M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.39M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $1.71M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $30.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $35.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $38.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $44.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $170.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $291.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $414.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $536.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $655.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $773.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $891.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $1.00M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.11M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.22M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $1.33M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.40M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.49M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $1.59M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.68M 10-K · filed 2021-03-18 |